Related by context. All words. (Click for frequent words.) 72 breast cancers 72 colorectal cancer 71 ovarian cancer 70 endometrial cancer 70 breast cancer recurrence 69 invasive cervical cancer 69 breast cancer 68 endometrial cancers 67 colorectal cancers 66 uterine cancers 66 HER2 positive breast cancer 65 lobular breast cancer 65 cervical cancer 65 colon cancer 64 ovarian cancers 64 rectal cancer 64 prostate cancers 63 oophorectomy 63 adenoma 63 nonmelanoma skin cancer 63 melanoma 63 lobular cancer 63 lung cancer 63 atypia 63 endometrial hyperplasia 62 DCIS 62 recurrent VTE 62 premenopausal 62 colorectal adenomas 62 premenopausal breast cancer 62 abnormal mammogram 62 atypical hyperplasia 62 HPV infection 62 BRCA mutations 62 colon cancers 61 epithelial ovarian cancer 61 advanced adenoma 61 advanced adenomas 61 prostate cancer 61 ductal cancer 61 tamoxifen 61 adenomas 61 pre cancerous lesions 61 postmenopausal breast cancer 61 tumor recurrence 61 breast carcinoma 61 BRCA2 mutations 61 nonmelanoma skin cancers 61 ductal breast cancer 61 breast tumors 60 precancerous lesions 60 vertebral fracture 60 HNSCC 60 venous thromboembolism 60 preeclampsia 60 postmenopausal women 60 recurrent stroke 60 pre cancerous polyps 60 colorectal polyps 60 colorectal cancer CRC 60 postmenopausal 60 hereditary breast cancer 60 hormone receptor positive 60 cardiovascular disease CVD 60 lobular carcinoma 60 ductal carcinoma 60 BRCA1 mutations 60 distant metastases 60 situ DCIS 60 malignancy 60 CaP 60 estrogen receptor negative 60 lung cancers 59 colorectal cancer incidence 59 cancers 59 post menopausal 59 medullary thyroid cancer 59 endometrial carcinoma 59 osteoporotic fracture 59 peritoneal cancer 59 gynecologic cancer 59 contralateral breast cancer 59 gastric cancer 59 malignant melanoma 59 cervical lesions 59 CMV infection 59 benign breast 58 ALCL 58 basal cell carcinomas 58 squamous cell cancers 58 pre eclampsia 58 pancreatic adenocarcinoma 58 pCR 58 venous blood clots 58 rectal cancers 58 malignancies 58 metastatic prostate cancer 58 chlamydial infection 58 bowel cancers 58 ovarian tumors 58 oropharyngeal cancer 58 CMV disease 58 bone metastasis 58 adenomatous polyps 58 lung tumors 58 spontaneous preterm delivery 58 VTE 58 HER2 positive cancers 58 colon polyps 58 osteoporotic fractures 58 BRCA mutation carriers 58 pre menopausal 58 cardiovascular disease 58 gynecologic cancers 57 metastatic disease 57 colorectal polyp 57 brain metastases 57 abnormal Pap test 57 Breast cancer 57 abnormal Pap 57 gynecologic malignancy 57 NSCLC 57 bowel cancer 57 BRCA mutation 57 ductal carcinomas 57 preterm delivery 57 gestational diabetes 57 invasive carcinoma 57 GnRH agonists 57 skin cancers 57 HER2 positive 57 tamoxifen therapy 57 bladder cancer 57 estrogen progestin therapy 57 metastatic breast cancer 57 BRCA2 mutation carriers 57 severe sepsis 57 ALND 57 breast carcinomas 57 polycystic ovary syndrome PCOS 57 Uterine cancer 57 axillary lymph nodes 57 abnormal mammograms 57 precancerous cervical 57 venous thrombosis 57 precancerous cervical lesions 57 vertebral fractures 57 invasive ductal 56 metastatic lung cancer 56 cancerous breast 56 carcinoma 56 prostate cancer CaP 56 nonsmall cell lung cancer 56 osteoporotic 56 metastatic cancer 56 localized prostate cancer 56 acute myelogenous leukemia AML 56 cervical cancers 56 Colorectal cancer 56 thrombotic events 56 spontaneous preterm birth 56 colorectal tumors 56 adenocarcinomas 56 breast cancer Narod 56 ovaries removed 56 bladder cancers 56 LQTS 56 epithelial ovarian 56 osteopenia 56 squamous cell carcinoma 56 HGPIN 56 ischemic stroke 56 CIN3 56 mutated BRCA1 56 pancreatic cancer 56 PSA screening 56 Barrett esophagus 56 Tamoxifen 56 micrometastases 56 pancreatic cancers 56 basal cell carcinoma BCC 56 HPV infections 56 Ovarian cancer 56 menopausal hormone therapy 56 endometriosis 56 operable breast cancer 56 Wilms tumor 56 pharyngeal cancer 56 uterine cancer 56 estrogen receptor positive 56 testicular cancers 56 mammographic density 55 gastrointestinal cancers 55 renal cell carcinomas 55 esophageal adenocarcinoma 55 adenocarcinoma 55 breast biopsies 55 atypical ductal hyperplasia 55 benign proliferative breast 55 prophylactic mastectomy 55 hormone therapy estrogen 55 estrogen therapy 55 melanomas 55 adjuvant therapy 55 anastrozole 55 liver cancer 55 lung adenocarcinoma 55 undergone hysterectomy 55 MetS 55 vulvar cancers 55 ischemic strokes 55 neoplasia 55 precancerous polyps 55 cardiovascular mortality 55 polyp recurrence 55 herpes zoster 55 renal cell carcinoma 55 liver metastases 55 Endometrial cancer 55 deCODE BreastCancer TM 55 NAFLD 55 Testicular cancer 55 pleural mesothelioma 55 endometriosis ovarian cysts 55 neoadjuvant chemotherapy 55 colorectal adenoma 55 metastatic colon cancer 55 Bladder cancer 55 perimenopausal women 55 undergoing bariatric surgery 55 metastatic renal cell carcinoma 55 malignant growths 55 hip fractures 55 postoperative atrial fibrillation 55 Lung cancer 55 adjuvant chemotherapy 55 basal cell nevus syndrome 55 intravenous bisphosphonates 55 ependymoma 55 distal colon cancer 55 osteosarcomas 55 Stomach cancer 55 Cholangiocarcinoma 54 definite stent thrombosis 54 squamous cell lung cancer 54 differentiated thyroid 54 BRCA1 mutation 54 mammary tumors 54 colorectal neoplasia 54 aromatase inhibitor 54 fallopian tube carcinoma 54 HPV 54 sentinel node biopsy 54 PSADT 54 oesophageal cancer 54 plus progestin 54 colon tumors 54 atrial fibrillation 54 Cervical cancer 54 PSA velocity 54 situ LCIS 54 follicular lymphoma 54 raloxifene 54 GISTs 54 prostate tumors 54 folic acid intake 54 breast tenderness 54 hip fracture 54 heart disease 54 lymphomas 54 uterine fibroids 54 BRCA2 mutation 54 cervical carcinoma 54 cancer 54 BRCA2 gene mutation 54 fibroadenomas 54 exemestane 54 undergone radical prostatectomy 54 breast cancer recurrences 54 systemic lupus erythematosus SLE 54 seminoma 54 preterm birth 54 esophageal cancers 54 bladder tumors 54 nonvertebral fractures 54 grade dysplasia 54 PCa 54 screening mammogram 54 Barrett Esophagus 54 ovulatory cycles 54 pre cancerous growths 54 baseline mammogram 54 Digital Mammographic Imaging 54 invasive ductal carcinoma 54 HCV infection 54 screening mammography 54 Ductal carcinoma 54 cervical intraepithelial neoplasia 54 glioblastoma 54 faulty BRCA genes 54 axillary dissection 54 SEER database 54 Hepatocellular Carcinoma HCC 54 asymptomatic carotid stenosis 54 malignant pleural mesothelioma 54 atherothrombotic events 54 MGUS 54 distant metastasis 54 androgen deprivation 54 EUS FNA 54 frequently benign tumor 54 Non Hodgkin lymphoma 53 carotid stenosis 53 Prostate cancer 53 ADPKD 53 gynecological cancers 53 meningioma 53 advanced neoplasia 53 bilateral oophorectomy 53 chlamydia infection 53 tibolone 53 malignant melanomas 53 benign growths 53 curable cancers 53 contralateral breast 53 coronary heart 53 hormone therapy 53 dutasteride 53 venous thromboembolic events 53 mycophenolate mofetil 53 uterine tumors 53 vulvar cancer 53 preterm deliveries 53 BRCA1 53 COPD 53 venous thromboembolism VTE 53 axillary lymph node dissection 53 lymphedema 53 abnormal Pap smears 53 cutaneous melanoma 53 hepatocellular carcinoma 53 squamous cell skin 53 HER2 negative 53 nonpregnant women 53 metastatic colorectal cancer 53 malignant tumors 53 BRCA gene mutation 53 salpingo oophorectomy 53 CHD mortality 53 Rectal cancer 53 tumors 53 preventive mastectomies 53 HPV# 53 Hodgkin lymphoma HL 53 thromboembolic events 53 anovulatory infertility 53 recurrent ovarian cancer 53 KRAS mutations occur 53 Breast Cancer Risk 53 endometrial 53 proliferative diabetic retinopathy 53 axillary node dissection 53 Malignant Melanoma 53 SLNB 53 clinically localized prostate 53 metastases 53 Pap smear 53 esophageal cancer 53 letrozole 53 mesotheliomas 53 eribulin 53 biochemical recurrence 53 BRCA1 mutation carriers 53 Uterine fibroids 53 precancerous colon polyps 53 recurrent myocardial infarction 53 hormonal therapy 53 CIN2 + 53 pelvic malignancies 53 locoregional 53 underwent prostatectomy 53 adjuvant radiation 53 ASCUS 53 periodontitis 53 dasatinib 53 malignant polyps 53 HER2 positive metastatic breast 53 Chlamydia infection 53 osteoporosis 53 thyroid cancers 53 bacterial vaginosis 53 vaginal cancers 53 medulloblastoma 53 estrogen progestin combination 53 thromboembolisms 53 subclinical hyperthyroidism 53 testicular germ cell 53 breast tissue 53 neural tube defect 53 bowel polyps 53 postoperative mortality 53 neoadjuvant therapy 53 grade gliomas 53 diffuse gastric 53 virologic failure 53 anal cancers 53 squamous cell cancer 53 #.#ng/ml 53 testicular tumors 53 CC genotype 53 serum phosphate 52 gestational hypertension 52 orchiectomy 52 thyroid cancer 52 laryngeal cancer 52 thyroid nodules 52 tumor subtypes 52 prophylactic mastectomies 52 T1DM 52 premenopausal women 52 cervical abnormalities 52 leiomyomas 52 gallstone disease 52 hemorrhagic strokes 52 uveal melanoma 52 Prostate Cancer Prevention 52 leukemia AML 52 hysterectomies performed 52 Cristofanilli 52 thromboembolic disease 52 ovarian 52 urothelial cancer 52 metachronous 52 prostate biopsy 52 Invasive Breast Cancer 52 intestinal polyps 52 relapsed ovarian cancer 52 sentinel nodes 52 Adjuvant chemotherapy 52 hormone receptor negative 52 coronary disease 52 EGFR mutation 52 chlamydia infections 52 acute leukemias 52 EGFR gene 52 colorectal bowel 52 trastuzumab 52 Recurrence Score 52 basal cell carcinoma 52 preterm births 52 elevated triglyceride levels 52 hyperemesis gravidarum 52 bone metastases 52 multiple gestations 52 cancerous lesions 52 premalignant 52 HER2 overexpression 52 invasive lobular carcinoma 52 progesterone receptor negative 52 prostate tumor 52 grade glioma 52 polycystic ovary syndrome 52 antigen PSA 52 lupus 52 ovulatory infertility 52 DVT PE 52 genital herpes infections 52 de ath 52 prostate cancer CRPC 52 folate supplementation 52 PCNSL 52 invasive ductal breast cancer 52 pelvic inflammatory disease 52 familial ALS 52 Androgen deprivation therapy 52 papillary thyroid cancer 52 bisphosphonate 52 Renal cell carcinoma 52 breast lesions 52 polyps 52 recurrent miscarriage 52 menopause 52 rectal carcinoma 52 RSV infects 52 gastric adenocarcinoma 52 prediabetes 52 extracolonic findings 52 androgen deprivation therapy 52 nonmetastatic 52 pre cancerous cells 52 reinfarction 52 undergoing hysterectomy 52 malignant lesions 52 cutaneous squamous cell carcinoma 52 breast endometrial 52 preoperative chemotherapy 52 nonvertebral fracture 52 screening colonoscopies 52 aromatase inhibitors 52 squamous cell carcinoma SCC 52 melanoma skin 52 Kaplan Meier analysis 52 elevated LDL cholesterol 52 hysterectomy 52 post thrombotic syndrome 52 cabazitaxel 52 vasomotor symptoms 52 Flexi Scope 52 androgen suppression therapy 52 aromatase inhibitors AIs 52 dysglycemia 51 grade cervical intraepithelial 51 squamous cell carcinomas 51 leukemia ALL 51 Heavy menstrual bleeding 51 elevated CRP 51 axillary nodes 51 superficial bladder cancer 51 sudden cardiac death 51 subclinical atherosclerosis 51 digital rectal exams 51 acute coronary syndrome 51 prostate cancer PCa 51 LNG IUS 51 precursor lesions 51 abnormal Pap smear 51 postmenopausal hormones 51 BRCA 51 pertuzumab 51 subclinical hypothyroidism 51 diabetes mellitus DM 51 precancerous polyp 51 undergo hysterectomy 51 carcinomas 51 NNRTI resistance 51 bronchopulmonary dysplasia 51 benign polyps 51 invasive pneumococcal disease 51 Colon polyps 51 myeloid leukemia 51 radical nephrectomy 51 serum PSA 51 pelvic lymphadenectomy 51 Polyps 51 myocardial infarction MI 51 HNPCC 51 prostate specific 51 seropositive patients 51 atypical fractures 51 complete cytogenetic response 51 precancerous 51 yearly mammograms 51 anti androgen 51 liver metastasis 51 thromboembolism 51 breast ovarian 51 disease progression 51 estrogen receptor ER 51 childhood leukemia 51 histologically confirmed 51 onset Alzheimer disease 51 renal flares 51 invasive cervical cancers 51 multiple myeloma 51 postmenopausal hormone 51 CHD CVD 51 premature menopause 51 rheumatoid arthritis RA 51 carcinoid tumors 51 ipsilateral stroke 51 renal carcinoma 51 HBV infection 51 lymph node metastases 51 VUR 51 uterine rupture 51 FOLFOX4 51 VTEs 51 coronary artery disease 51 coronary calcification 51 nonproliferative 51 medulloblastomas 51 hepatocellular cancer 51 Femara 51 KRAS status 51 postoperative pulmonary 51 nonfatal MI 51 genital HPV 51 oral bisphosphonates 51 glioma rarer 51 gliomas 51 systemic scleroderma 51 Thyroid cancer 51 severe psoriasis 51 carcinoid cancer 51 ovarian hyperstimulation syndrome OHSS 51 SCCHN 51 autoantibody positive 51 serous ovarian cancer 51 endometrial tumors 51 symptomatic fibroids 51 Pancreatic neuroendocrine tumors 51 relapsing remitting multiple sclerosis 51 glioma 51 pharyngeal cancers 51 gynecological cancer 51 atrophic gastritis 51 EBRT 51 colorectal 51 Premenopausal women 51 biochemical relapse 51 colorectal carcinoma 51 node metastases 51 breast conserving 51 curative resection 51 recurrent preterm birth 51 choriocarcinoma 51 bisphosphonate therapy 51 candidemia 51 HIV infection 51 histological subtype 51 recurrent metastatic 51 external genital lesions 51 pulmonary metastases 51 progestins 51 IV melanoma 51 precancerous condition 51 zoledronic acid 51 colon adenomas 51 AAT deficiency 51 irregular menstrual cycles 51 vaginal atrophy 51 nonhormonal 51 kidney transplant recipients 51 microalbuminuria 51 fibroids 51 Pap smear screening 51 gestational diabetes mellitus GDM 51 contrast induced nephropathy 51 medically inoperable 51 Ovary removal 51 endometrial lining 51 lung metastasis 51 lymph node involvement 51 Framingham Offspring Study 51 basal cell skin 51 gout flares 51 standard chemotherapy regimen 51 sentinel lymph node biopsy 51 pre cancerous 51 blood clots 51 lymph node removal 51 statins 51 oesophageal adenocarcinoma 51 dose aspirin 51 colon polyp 51 adenoma recurrence 51 diverticular bleeding 51 ectopic pregnancies 51 relapsed MM 51 WNV infection 51 knee osteoarthritis 50 drank decaffeinated coffee 50 flutamide 50 chemoradiation 50 melanoma tumors 50 brain tumors 50 folic acid supplement 50 colorectal liver metastases 50 HPV types 50 prostate pancreatic 50 telomere lengths 50 glucose intolerance 50 transitional cell carcinoma 50 ICDs implanted 50 prescribed statins 50 Screening Trial 50 acute myeloid leukemia AML 50 underwent surgical resection 50 premalignant lesions 50 Anal cancer 50 homozygous familial hypercholesterolemia 50 hip BMD 50 HER2 positive tumors 50 UTIs 50 dietary folate intake 50 cranial radiation 50 hydroxyvitamin D levels 50 recurrent UTI 50 sexually transmitted infection 50 invasive meningococcal disease 50 intracerebral hemorrhage 50 tumor shrinkage 50 polyp detection 50 resected pancreatic cancer 50 Glioblastoma 50 resistant ovarian cancer 50 prostate adenocarcinoma 50 cisplatin resistant 50 AVODART 50 metastatic kidney 50 preterm labor 50 premenstrual syndrome PMS 50 haemorrhagic stroke 50 obstetric complications 50 hematopoietic cancers 50 recurrent UTIs 50 hepatocellular carcinoma HCC 50 lipid lowering drugs 50 precancerous tumors 50 screening mammograms 50 colon breast 50 Hydroxyurea 50 colorectal neoplasms 50 RSV infection 50 neoplasia PIN 50 colorectal tumor 50 carotid endarterectomy 50 conjugated equine estrogens 50 Torisel 50 undergoing radical prostatectomy 50 HPV genotypes 50 antiplatelet therapy 50 cerebral infarction 50 screening colonoscopy 50 heavily pretreated 50 BRCA deficient 50 neural tube birth defects 50 neuroblastoma 50 cervical dysplasia 50 Malignant gliomas 50 BRCA carriers 50 familial adenomatous polyposis 50 chronic HCV infection 50 troponin T 50 upper gastrointestinal bleeding 50 surgical biopsies 50 overt hepatic encephalopathy HE 50 tanned indoors 50 carcinoma HNSCC 50 locoregional recurrence 50 carcinoid tumor 50 microbleeds 50 Basal cell carcinoma 50 Folfox 50 coronary artery calcium 50 tumor histology 50 KRAS mutation 50 highest quintile 50 olaparib 50 cardiovascular hospitalization 50 arterial thickening 50 DMPA 50 hemorrhagic complications 50 human papillomavirus HPV 50 spine fractures 50 Helicobacter pylori infection 50 Prostate Lung Colorectal 50 Renal Cell Carcinoma RCC 50 metastatic lesions 50 alcoholic cirrhosis 50 oral contraceptive pills 50 benign prostatic hypertrophy 50 transfusion syndrome 50 ovarian lung 50 eosinophilic pneumonia 50 Pap test 50 recurrent atrial fibrillation 50 neural tube defects 50 atherosclerotic disease 50 Carcinoma 50 genital HPV infection 50 pegylated liposomal doxorubicin 50 prostate biopsies 50 CYPHER Stent 50 CIN3 + 50 recurrent NSCLC 50 leukaemias 50 knee OA 50 axillary node 50 Screening Trial DMIST 50 ovulation induction 50 invasive lobular 50 MS relapses 50 squamous cell 50 R0 resection 50 gonorrhea infections 50 Esophageal cancer 50 β blockers 50 hepatitis C genotype 50 ectopic pregnancy 50 breastfed exclusively 50 Bowel cancer 50 artery blockages 50 Zometa 50 APOL1 50 invasive aspergillosis 50 preventive mastectomy 50 noncancer 50 folate intake 50 prednisone prednisolone 50 malignant neoplasms 50 HbA1c levels 50 BRCA2 50 adjuvant radiotherapy 50 lupus nephritis 50 ocular toxicity 50 letrozole Femara 50 Hurthle cell 50 artery calcification 50 metastatic 50 acrylamide intake 50 undergo prostate biopsy 50 STEMI patients 50 recurrent ovarian 50 parous women 50 progestin 50 diagnose Alzheimer disease 50 gastrointestinal malignancies 50 Median survival 50 colectomy 50 metastatic RCC 50 non metastatic osteosarcoma 50 atypical femur fractures 50 metabolic syndrome 50 desogestrel 50 castration resistant prostate cancer 50 mCRC patients 50 atopic disease 50 ductal lobular 50 abnormal uterine bleeding 50 abnormal cytology 50 abnormal cervical 50 thrombotic complications 50 EXJADE 50 folic acid takers 50 bisphosphonates 50 clodronate 50 ovarian carcinoma 50 tamsulosin 50 urolithiasis 50 BRCA gene mutations 50 postmenopausal osteoporosis 50 aneuploidy 50 PAOD 50 non Hodgkin lymphomas 50 undergoing coronary angiography 50 gestational diabetes mellitus 50 mL/min/#.# m 2 50 benign lesions 50 urinary symptoms 50 undergone hysterectomies 50 atypical lobular hyperplasia 50 IKZF1 50 confidence interval #.#-#.# 50 urothelial carcinoma 50 Halaven 49 polycythemia vera 49 deep venous thrombosis 49 metastatic tumors 49 postmenopause 49 osteosarcoma 49 colon rectal cancer 49 cetuximab 49 asymptomatic 49 cervical vaginal 49 systemic lupus erythematosus 49 GnRH agonist 49 esophageal squamous cell carcinoma 49 histologic subtype 49 mammographic screening 49 anal cancer 49 perinatal mortality 49 recurrent venous thromboembolism 49 Osteosarcoma 49 non squamous NSCLC 49 BRCA genes 49 Oesophageal cancer 49 Zolinza 49 chromosomal abnormalities 49 carcinoid 49 GIST 49 Chronic Lymphocytic Leukemia CLL 49 perioperative mortality 49 Cancers 49 contralateral prophylactic mastectomy 49 fragility fractures 49 elevated depressive symptoms 49 Adenomas 49 gene BRCA2 49 proliferative retinopathy 49 metastatic HER2 positive 49 chronically immunosuppressed solid 49 cystectomy 49 precancers 49 BRCA1 gene 49 neoplasm 49 neovascular AMD 49 statin 49 SUVmax 49 liver transplant recipients 49 genetic variants associated 49 prophylactic oophorectomy 49 selenium supplementation 49 Thyroid nodules 49 GIST tumors 49 Velcade bortezomib 49 malignant neoplasm 49 type 1diabetes 49 metastatic prostate 49 zoledronic acid Zometa 49 CHD 49 HER2 expression 49 chronic bilirubin encephalopathy 49 TORISEL 49 hemodialysis patients 49 Human papilloma virus 49 lymphoma 49 atherosclerotic progression 49 adrenal tumors 49 clinically detectable 49 progestogen 49 postoperative pathology 49 autoantibodies 49 fetal malformations 49 cranial irradiation 49 ruptured aneurysms 49 recurrences 49 stable angina 49 Fibroids 49 severe periodontitis 49 invasive MRSA infections 49 NSAID 49 chronic lymphocytic leukemia CLL 49 KRAS mutations 49 thoracic aortic disease 49 symptomatic BPH 49 sentinel node 49 IV bisphosphonates 49 CVD mortality 49 POAG 49 Caesarean deliveries 49 Chlamydia infections 49 SHPT 49 paroxysmal AF 49 cystatin C 49 PLCO 49 Gastric cancer 49 preoperative radiotherapy 49 angiosarcoma 49 Recurrences 49 rotavirus infections 49 Tavocept 49 disease NAFLD 49 prognostic variables 49 adalimumab 49 Preeclampsia 49 perioperative morbidity 49 benign nodules 49 excessive menstrual bleeding 49 response pCR 49 fetal chromosomal 49 lignan intake 49 conjugated equine estrogen 49 recurrent prostate cancer 49 gastrointestinal GI cancers 49 acute GVHD 49 metastatic malignant 49 octreotide LAR 49 cisplatin 49 Oral contraceptives 49 DLBCL 49 endogenous estrogen 49 thyrotropin levels 49 cervical precancers 49 myocardial infarction 49 Follicular Lymphoma 49 oral contraception 49 neoadjuvant radiation 49 S. aureus infections 49 Prostate Specific Antigen PSA 49 malignant lymphoma 49 postoperative delirium 49 risedronate 49 San Antonio Breast Cancer 49 prostate cancer mCRPC 49 synovial sarcoma 49 acute myeloid leukemia 49 oral contraceptives 49 ovarian hyperstimulation 49 highest tertile 49 NHANES III 49 penile cancers 49 uterine ovarian 49 nonobstructive CAD 49 hsCRP levels 49 retrospective cohort 49 mammographies 49 epithelial tumors 49 HSCT